BUZZ-帕利塞德生物公司股价上涨；肠道疾病药物将成为全球会议的焦点

路透中文

Jan 16

BUZZ-帕利塞德<a href="https://laohu8.com/S/000504">生物</a>公司股价上涨；肠道疾病药物将成为全球会议的焦点

1月16日 - ** 药物开发商Palisade Bio PALI.O的股价盘前上涨1.7%至1.78美元

** 该公司表示，其试验性溃疡性结肠炎药物PALI-2108将在明年的两个大型医学会议上亮相

** 溃疡性结肠炎是一种慢性肠道疾病，会导致结肠发炎和出血

** PALI表示，早期数据显示所有患者都有反应，没有严重的安全性问题

** 计划在拉斯维加斯克罗恩病和结肠炎大会以及斯德哥尔摩欧洲克罗恩病和结肠炎组织大会上发表演讲 - PALI

** 表示正在准备一项为期 12 周的更大规模研究，并计划开展克罗恩病研究

** 截至上次收盘，股价在过去一年中上涨了约 42%

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603991704"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603991704\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603991704?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-16 22:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603991704","market":"us","top_or_hot":-1,"title":"BUZZ-帕利塞德生物公司股价上涨；肠道疾病药物将成为全球会议的焦点","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-帕利塞德<a href=\"https://laohu8.com/S/000504\">生物</a>公司股价上涨；肠道疾病药物将成为全球会议的焦点</title></head><body><p><span>1月16日</span><span> - </span>** 药物开发商<a href=\"https://laohu8.com/S/PALI\">Palisade Bio</a> <span>PALI.O</span>的股价盘前上涨1.7%至1.78美元 </p><p>** 该公司表示，其试验性溃疡性结肠炎药物PALI-2108将在明年的两个大型医学会议上亮相</p><p>** 溃疡性结肠炎是一种慢性肠道疾病，会导致结肠发炎和出血</p><p>** PALI表示，早期数据显示所有患者都有反应，没有严重的安全性问题</p><p>** 计划在拉斯维加斯克罗恩病和结肠炎大会以及斯德哥尔摩欧洲克罗恩病和结肠炎组织大会上发表演讲 - PALI</p><p>** 表示正在准备一项为期 12 周的更大规模研究，并计划开展克罗恩病研究</p><p>** 截至上次收盘，股价在过去一年中上涨了约 42% </p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-帕利塞德生物公司股价上涨；肠道疾病药物将成为全球会议的焦点</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-帕利塞德生物公司股价上涨；肠道疾病药物将成为全球会议的焦点\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-01-16 22:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-帕利塞德<a href=\"https://laohu8.com/S/000504\">生物</a>公司股价上涨；肠道疾病药物将成为全球会议的焦点</title></head><body><p><span>1月16日</span><span> - </span>** 药物开发商<a href=\"https://laohu8.com/S/PALI\">Palisade Bio</a> <span>PALI.O</span>的股价盘前上涨1.7%至1.78美元 </p><p>** 该公司表示，其试验性溃疡性结肠炎药物PALI-2108将在明年的两个大型医学会议上亮相</p><p>** 溃疡性结肠炎是一种慢性肠道疾病，会导致结肠发炎和出血</p><p>** PALI表示，早期数据显示所有患者都有反应，没有严重的安全性问题</p><p>** 计划在拉斯维加斯克罗恩病和结肠炎大会以及斯德哥尔摩欧洲克罗恩病和结肠炎组织大会上发表演讲 - PALI</p><p>** 表示正在准备一项为期 12 周的更大规模研究，并计划开展克罗恩病研究</p><p>** 截至上次收盘，股价在过去一年中上涨了约 42% </p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nL4T3YH169:1","article_id":"2603991704","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603991704","pubTimestamp":1768573262,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","PALI":"Palisade Bio Inc.","BK4139":"生物科技"},"translate_title":"BUZZ-Palisades Biologics Stock Rises; Drugs for intestinal diseases to be the focus of global conference","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PALI":0.9},"content_text":"BUZZ-帕利塞德生物公司股价上涨；肠道疾病药物将成为全球会议的焦点1月16日 - ** 药物开发商Palisade Bio PALI.O的股价盘前上涨1.7%至1.78美元 ** 该公司表示，其试验性溃疡性结肠炎药物PALI-2108将在明年的两个大型医学会议上亮相** 溃疡性结肠炎是一种慢性肠道疾病，会导致结肠发炎和出血** PALI表示，早期数据显示所有患者都有反应，没有严重的安全性问题** 计划在拉斯维加斯克罗恩病和结肠炎大会以及斯德哥尔摩欧洲克罗恩病和结肠炎组织大会上发表演讲 - PALI** 表示正在准备一项为期 12 周的更大规模研究，并计划开展克罗恩病研究** 截至上次收盘，股价在过去一年中上涨了约 42% (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}